BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11109632)

  • 1. [Genetic diversity of viruses. Consequences for screening and prevention].
    Barin F; Laperche S; Couroucé AM
    Transfus Clin Biol; 2000 Oct; 7(5):472-8. PubMed ID: 11109632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
    Laperche S
    Transfus Clin Biol; 1998 Apr; 5(2):139-46. PubMed ID: 9618839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
    Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controlled viral risks].
    Barin F
    Transfus Clin Biol; 2000 Feb; 7(1):24-9. PubMed ID: 10730343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Noise' in microbiological screening assays.
    Dow BC
    Transfus Med; 2000 Jun; 10(2):97-106. PubMed ID: 10849378
    [No Abstract]   [Full Text] [Related]  

  • 8. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus.
    Gonçales FL; Pereira JS; Da Silva C; Thomaz GR; Pavan MH; Fais VC; Magna LA; Gonçales NS
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):718-20. PubMed ID: 12853411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yield and future issues of nucleic acid testing.
    Roth WK; Seifried E
    Transfus Clin Biol; 2001 Jun; 8(3):282-4. PubMed ID: 11499978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
    Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
    J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for viral markers in volunteer and replacement blood donors in West Africa.
    Sarkodie F; Adarkwa M; Adu-Sarkodie Y; Candotti D; Acheampong JW; Allain JP
    Vox Sang; 2001 Apr; 80(3):142-7. PubMed ID: 11840974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycles.
    Cobo A; Bellver J; de los Santos MJ; Remohí J
    Fertil Steril; 2012 Jan; 97(1):74-8. PubMed ID: 22035968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.
    Antar W; El-Shokry MH; Abd El Hamid WA; Helmy MF
    Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
    Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
    Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1].
    Laperche S; Maniez-Montreuil M; Couroucé AM
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():18s-24s. PubMed ID: 10919219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.